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Abstract: Stress is a major driving force in alcohol use disorders (AUDs). It influences 
how much one consumes, craving intensity and whether an abstinent individual will return 
to harmful alcohol consumption. We are most vulnerable to the effects of stress during 
early development, and exposure to multiple traumatic early life events dramatically 
increases the risk for AUDs. However, not everyone exposed to early life stress will 
develop an AUD. The mechanisms determining whether an individual’s brain adapts and 
becomes resilient to the effects of stress or succumbs and is unable to cope with stress 
remain elusive. Emerging evidence suggests that neuroplastic changes in the nucleus 
accumbens (NAc) following early life stress underlie the development of AUDs. This 
review discusses the impact of early life stress on NAc structure and function, how these 
changes affect cholinergic signaling within the mesolimbic reward pathway and the role 
nicotinic acetylcholine receptors (nAChRs) play in this process. Understanding the neural 
pathways and mechanism determining stress resilience or susceptibility will improve our 
ability to identify individuals susceptible to developing AUDs, formulate cognitive 
interventions to prevent AUDs in susceptible individuals and to elucidate and enhance 
potential therapeutic targets, such as the nAChRs, for those struggling to overcome an 
AUD. 
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1. Alcohol Use Disorders: What’s All the Stress About? 
Alcohol use disorders (AUDs) constitute a major global health issue and there remains a critical  
need for the development of medications for the treatment of AUDs. Stress is a significant  
contributing factor in AUDs [1-3] and the ability to cope with stress (known as resilience) inversely 
predicts the development of a stress-related neuropsychiatric disease, including AUDs [4].  
Susceptibility to AUDs is determined by both genetic and environmental factors [1,5,6].  
However, chronic exposure to an adverse environment dramatically increases the risk toward  
developing AUDs [6-8]. Research indicates that this is not a passive process; that individuals are able 
to learn to be resilient by developing protective mechanisms that shield them from the maladaptive 
effects of stress [4]. Early life stress (ELS) has been identified as a significant factor contributing to the 
development of numerous stress-related psychiatric disorders [1,4-6,9,10]. Children with a family 
history of alcoholism are particularly vulnerable to developing psychiatric disorders later in life.  
Their family history of alcoholism not only increases their risk of developing AUDs: it places them at 
an increased risk for exposure to an aversive environment in early life [7,11]. For these children it is a 
vicious cycle as exposure to multiple traumatic early life events increases the risk of developing AUDs 
approximately seven-fold [7]. Understanding the neural pathways involved and the mechanism  
that determine resilience or susceptibility to the effects of stress will improve our ability to identify 
individuals susceptible to developing AUDs, formulate cognitive interventions to prevent the 
development of AUDs in susceptible individuals and to elucidate and enhance potential therapeutic 
targets such as the nicotinic acetylcholine receptors (nAChRs) for those already struggling to 
overcome an AUD. 
2. The Two-Way Interplay Between Stress and Alcohol Controls Alcohol Consumption 
Stress is a major driving force in AUDs [1-3,5,12-15]. It influences how much alcohol an individual 
consumes (for review see [16]), how intensely one craves alcohol (for reviews see [17,18]) and 
ultimately whether an abstinent individual will return to harmful alcohol consumption [2,16-20]. 
Additionally, the chronic consumption of alcohol alters the normal function of the stress system 
causing an increased susceptibility to stress [19]. This has devastating consequences for the 
progression of AUDs as it produces a cycle of degeneration where exposure to stress leads to 
escalations in alcohol consumption, further reducing the ability to cope with stress and shortening the 
length of intervals between periods of abstinence. 
3. Stress Changes How the Brain Functions 
The mechanisms underlying the brain’s response to stress are well understood. In the brain stressful 
events trigger the release of corticotrophin releasing hormone (CRH) and vasopressin from the 
paraventricular nucleus of the hypothalamus. This causes the pituitary to secrete adrenocorticotropic 
hormone (ACTH), resulting in the release of glucocorticoids (primarily cortisol in humans, 
corticosterone in rodents) from the adrenals (Figure 1) [16,21]. 
Brain Sci. 2015, 5 4 
 
 
 
Figure 1. The stress response. Stressful events trigger the release of corticotrophin 
releasing hormone (CRH) from the hypothalamus which results in the release of 
adrenocorticotropic hormone (ACTH) from the pituitary into the blood. This causes 
glucocorticoids to be released from the adrenals which bind to glucocorticoid (GRs) and 
mineralocorticoid (MRs) receptors creating a negative feedback circuit, ending the stress 
response and restoring allostasis. Adapted from [22]. 
Although there are many different types of receptors in the brain that mediate alcohol consumption 
and seeking behaviours (for reviews see [23-25]), it is currently presumed that glucocorticoids do not 
act directly at these receptors. Rather, it is proposed that glucocorticoids, via mineralocorticoid (MR) 
and glucocorticoid (GR) receptors, alter the activity and excitability of neurons by facilitating or 
inhibiting the signaling of ion channels, receptors and neurotransmitters and the consumption of 
alcohol relieves the effects of the alterations caused by stress (for review see [21]). Research indicates 
that MRs play a prominent role in acute stress responses as they act to maintain allostasis (allostasis is 
the process of maintaining stability, or homeostasis, during change (see [26,27])). GRs, on the other 
hand act during chronic stress, where allostasis cannot be restored and instead the system must adapt to 
the new environment by using inefficient stress response processes (known as allostatic load) (for 
reviews see [27-29]). Despite the cost of maintaining allostatic load, the actions of glucocorticoids and 
GR can remain protective, promoting neuroplastic changes with positive effects. However, when the 
system becomes overrun (allostatic overload) the actions of the glucocorticoids become damaging and 
the GR-mediated changes in gene transcription, chemical signaling and brain morphology lead to 
disease such as depression and AUDs [28]. 
It is clear from human studies that not everyone who experiences stress will become an alcoholic; 
stress-induced increases in alcohol intake are limited to alcohol-dependent individuals and individuals 
demonstrating traits associated with elevated stress (anxiety and depression) [30,31]. We know these 
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differences in susceptibility to stress-related disorders result from a complex interaction of the 
individuals’ genetics and life experiences (for reviews see [6,32,33]). Additionally we know that 
stressful experience(s) in early life plays an important role in this interaction [5,6,34]; but the exact 
mechanisms determining stress resilience or susceptibility have remained elusive. In recent years there 
is an increasing number of studies that suggest neuroplastic changes within the nucleus accumbens 
(NAc) following exposure to ELS may underlie the development of numerous neuropsychiatric 
disorders including AUDs [35-47]. 
4. AUDs and the Nucleus Accumbens 
Alcohol changes the function of the NAc. Rodent studies have shown that exposure to alcohol 
enhances activation of the NAc [48,49], alters NAc dopamine [50] and glutamate [51-53] transmission 
and modifies dendritic structure [54]. These studies also show that ethanol has differential effects on 
the NAc core and the shell. In the NAc shell ethanol alters dendrite morphology [55], cFos expression 
[56] and gamma amino butyric acid (GABA) [57] and dopamine [58] signaling. Whereas, in the NAc 
core ethanol exposure alters dendrite morphology [54], glutamate signaling [52-54] and mitogen-
activated protein kinase (MAPK) expression [48]. In humans, a family history of alcoholism is 
associated with altered NAc volume and NAc functional connectivity. Consistent with studies showing 
that females are more vulnerable to the effects of ELS [41,59-61] and two times more likely to develop 
AUDs following ELS [7], a link between altered left NAc volume and a family history of alcoholism 
has been reported for adolescent females but not males [62]. Human studies into schizophrenia show 
similar disruptions in NAc-prefrontal cortex (PFC) connectivity and suggest that changes in the NAc 
shell may mediate the positive symptoms associated with schizophrenia (For reviews see [47,63-65]). 
5. Early Life Stress Causes Neuroplastic Changes in the Nucleus Accumbens 
Exposure to ELS also impacts the function of the NAc. In rodents, exposure to ELS alters  
dopamine [35,66,67] and serotonin signaling in the NAc [68,69]. Both neurotransmitters modulate 
relapse to alcohol seeking [25,68,70]. Changes in expression of genes and proteins involved in the 
stress response, like GRs and corticotrophin releasing hormone (CRH) receptors have also been found 
following exposure to ELS [71,72]. In humans, exposure to ELS has been linked to reduced NAc 
reactivity [37]. This contradicts the popular hypothesis that the positive symptoms of schizophrenia are 
due to reduced GABA-mediated inhibition of the NAc [47]. Differences in sex and the type and 
number of exposures to ELS may account for the discrepancies in these findings. 
Research into the effects of ELS on the NAc shell and core is still in its early stages. Enhancement 
of estrogen, oxytocin and serotonin-1A receptor expression have been found in the NAc shell 
following exposure to short periods of maternal separation in female rodents [69]. This type of ELS is 
thought to model stress resilience [10,73,74]. In females, the interaction of these three receptors is 
proposed to be critical in the development of anxiety and depression disorders [69,75,76]. In the NAc 
core reductions of methyl CpG binding protein 2 (MeCP2) were found following ELS in rodents [40]. 
MeCp2 is commonly used as an epigenetic marker. A growing number of studies have provided 
evidence suggesting that ELS causes epigenetic changes in gene transcription of the GRs contributing 
to disruptions in the mesolimbic pathway [77-89]. Much more research is required to further elucidate 
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the roles of the NAc core and shell in the development of stress resilience and susceptibility and how 
this contributes to the development of AUDs. 
6. Nucleus Accumbens Regulates Cholinergic Output to PFC 
The NAc modulates the activity of the basal forebrain which is the major projection site for 
cholinergic neurons within the brain [47,63,90-93]. The basal forebrain cholinergic neurons project to 
most of the cortex, including the PFC. Changes in cholinergic output to the PFC (which is responsible 
for differentiating between conflicting thoughts, like good vs bad, prediction of future consequences 
and urge suppression) have been proposed to underlie the symptoms of numerous psychiatric disorders 
including PTSD, schizophrenia and major depression (for reviews see [42,47,63-65,94-96]). It is has 
been proposed that there is a reduction in GABAergic inhibition of NAc activity from the amygdala 
and VTA which leads to enhanced activation of the PFC (for reviews see [47,97]). The PFC in turn 
regulates activity of VTA and amygdala producing a generalized malfunction of mesolimbic pathway 
[47,92,98-100]. Cholinergic neurons regulate most of the mesolimbic pathway via the release of 
acetylcholine (ACh); including the amygdala, NAc, VTA and PFC [92,98]. ACh binds to nAChRs 
which are capable of modulating the release of dopamine and hence the rewarding and reinforcing 
properties of numerous drugs, including alcohol [58,101-105]. 
7. What are nAChRs and How are They Involved in AUDs? 
nAChRs are pentameric ligand-gated ion channels consisting of different combinations of α2–α10 
and β2–β4 subunits [106] (Figure 2). Their endogenous ligand is ACh but they also bind nicotine. In a 
similar manner to glucocorticoids, ethanol does not modulate nAChRs directly: it instead increases the 
release of ACh. The type of subunits that make up the nAChR and their location in the brain influences 
the functional properties of the receptor. For example, in the ventral tegmental area (VTA) activation 
of α4/α6β4 containing (*) nAChRs modulates dopaminergic transmission whereas, α7 nAChRs 
modulate glutamate release and α4β2*nAChRs the release of GABA [107]. nAChRs are expressed on 
neurons within the mesolimbic dopaminergic pathway (Figure 3) which mediates the rewarding and 
reinforcing properties of ethanol [102,108,109]. 
 
Figure 2. Nicotinic acetylcholine receptors (nAChRs) consist of different combinations of 
alpha (α) and beta (β) subunits. Variations in the subunit composition not only determine 
the number of binding sites for their endogenous ligand, acetylcholine (ACh) but also the 
functional properties of the receptor. Taken from [110]. 
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Figure 3. Nicotinic acetylcholine receptors (nAChRs) are located within brain structures 
involved in modulating alcohol addiction and stress. nAChRs are found within the 
mesolimbic pathway (hippocampus, prefrontal cortex (PFC), nucleus accumbens (NAc), 
amygdala and ventral tegmental area (VTA)). These regions also express glucocorticoid 
receptors (GR) and participate in glutamatergic (blue), GABAergic (green), dopaminergic 
(red) and cholinergic (orange) neurotransmission.  Adapted from [111]. 
Ethanol triggers the release of ACh in the VTA which causes dopamine to be released in the  
NAc [58,101,104,105]. The release of dopamine in this area is responsible for the mood-altering 
properties of ethanol: that is consumption of alcohol causes increases in dopamine making you “feel 
good” and decreases, like that which occurs during withdrawal, make you “feel bad” [102]. This effect 
is mediated by nAChRs as it can be blocked by the intra-VTA administration of mecamylamine, a  
non-selective nAChR antagonist [58,101,104]. The NAc responds to changes in dopamine levels by 
altering the activity of the cholinergic neurons of the basal forebrain, which project throughout most of 
the brain and heavily innervate the cortex [47,99,100,112,113]. Extra-hypothalamic structures involved 
in the mesolimbic dopaminergic pathway, such as the PFC, hippocampus, amygdala, NAc and VTA, 
also modulate the stress-HPA axis and are innervated by basal forebrain cholinergic neurons (Figure 
3). 
8. Nicotinic Acetylcholine Receptors are Modulated by Alcohol and Stress 
The cholinergic system plays an important role in mediating AUDs (for reviews see [114,115]). 
Alcohol consumption and withdrawal affect ACh release in the brain [116,117] and compounds which 
alter the function of nicotinic acetylcholine receptors (nAChRs) reduce alcohol consumption and 
reinstatement of ethanol seeking [118-121]. It is also well known that stress alters the function of the 
cholinergic system [1,122,123]. This is not surprising given that ACh primarily acts as a 
neuromodulator, altering the state of neurons in response to changing environmental stimuli (for 
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review see [98]) similar to glucocorticoids in response to stressful events. We also know that nAChRs 
are involved in the stress response. Mecamylamine, a non-selective nAChR antagonist, prevents CRH-
induced increases in plasma corticosterone [124]. It also prevents nicotine-induced increases in urinary 
corticosterone [125] and stress-induced reinstatement of conditioned place preference to ethanol [20]. 
However, it is unknown which types of nAChRs and how their location within the brain modulates this 
process. 
9. nAChR Subtypes and Their Role in Stress and AUDs 
If you consider that ACh is a neuromodulator and nAChRs are located in the mesolimbic and  
stress-HPA axis systems, the cholinergic system is ideally situated for modulating alcohol 
consumption and relapse in response to stress. However; the precise role of the individual subunits 
comprising nAChRs involved in this process and the importance of their location remained relatively 
unexplored until recently. There is growing evidence suggesting the α4 subunit plays a prominent role 
in alcohol consumption driven by stress. Human genetic studies have indicated that mutations in the 
CHRNA4 gene, encoding the α4 subunit, is linked to a vulnerability to both alcoholism [126]  
and depression [122]. It has also been shown that TC-2559, an α4β2*nAChR selective agonist,  
increases urinary corticosterone [125]; varenicline, a partial agonist at α4β2*nAChRs, reduces ethanol 
consumption [120]; and prenatal stress alters α4β2*nAChR expression in the hippocampus [127]. 
Additionally our laboratory has shown that exposure to ethanol alters α4*nAChR expression in the 
NAc, amygdala and VTA of mice (unpublished data). 
While circumstantial, this evidence suggests that α4*nAChRs could be an important link between 
AUDs and stress. Interestingly, human studies have found an association between a family history of 
alcoholism and: left NAc volume in adolescent females [62]; resting state connectivity of the NAc 
[128]; and NAc connectivity during reward [129,130] suggesting these individuals have less 
segregation between the NAc and executive functioning brain regions (like the PFC), and less 
integration with reward-related brain areas (like the amygdala and VTA). As previously discussed all 
these brain regions are innervated by cholinergic neurons and contain nAChRs with α4 subunits. 
Changes in NAc activity were also found following recent negative life stress in individuals with major 
depressive disorder [38]. Furthermore, polymorphisms in the CHRNA4 gene have been linked to 
major depression [122] and negative emotionality [131]. While it seems highly likely that the NAc 
modulates stress-driven alcohol consumption and relapse via α4*nAChRs, it is however difficult to 
determine whether the α4 subunit is acting alone or in combination with the β4 subunit as the studies 
discussed above do not explore this possibility. This may be due to the technical difficulties involved 
separating the functional properties of the individual subunits and the fact that both subunits tend to be 
expressed together within the brain. Recent advances in transgenic technology utilizing fluorescent 
tags attached to the various nAChR subunits have the potential for isolating the roles of the individual 
subunits in this process. 
While it has been established that α4*nAChRs are important in AUDs [118,120,126], recent 
research indicates that there are other subtypes involved. A study by Chatterjee et al (2011) [119] 
shows that pharmacological modulation of α3β4*nAChRs reduces ethanol consumption in rats. More 
recently Cippitelli et al (2015) [132] confirmed this finding by demonstrating that pharmacological 
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modulation of α3β4*nAChRs reduces ethanol consumption and blocks stress-induced but not cue-
induced reinstatement to ethanol seeking, suggesting that the partial α3β4*nAChR agonist (AT-1001) 
is alleviating the effects of stress rather than the effects of ethanol. Homomeric α7 nAChRs may also 
be important modulators of stress and alcohol consumption. Expression of α7 nAChRs are altered in 
the frontal cortex and hippocampus following exposure to prenatal stress [133,134]. Additionally, a  
selective α7 nAChR partial agonist SSR180711, administered ex vivo caused an increase in dopamine 
in the PFC [135]. The effect of SSR180711 was blocked when the selective α7 nAChR antagonist, 
methyllycaconitine was employed. Changes in nAChR-mediated dopamine signaling in PFC has the 
potential to alter the activity of the NAc, amygdala and basal forebrain leading to changes in alcohol 
craving in response to stress. Interestingly, α7 nAChRs have been implicated in alcohol consumption, 
ELS and schizophrenia [127,134-136]. However, the role of these and other nAChR subtypes in stress 
resilience and susceptibility following ELS remains relatively unexplored. 
10. Conclusions 
While the role of nAChRs is well established in ethanol consumption and relapse, much more 
research is required to elucidate the contribution the various nAChR subtypes make in the 
development of AUDs. Even less is known about their role in stress and stress resilience and how this 
impacts both the development and progression of AUDs. Emerging evidence indicates that NAc-
mediated changes in the cholinergic output from the basal forebrain following exposure to ELS play a 
critical role in the development of AUDs (and other disorders) later in life. However, it remains to be 
determined what role the nAChRs play in this process. Gaining greater insight into the role of nAChRs 
in stress resilience will further our ability to identify individuals at risk of developing AUDs, prevent 
the development of AUDs in those at risk and develop better pharmacotherapeutics to treat those 
struggling with an AUD. 
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